What drug class does Mavik (tafamidis) belong to?

Mavik Drug Class

Mavik (trandolapril) is an ACE inhibitor (angiotensin-converting enzyme inhibitor), not tafamidis. 11

Important Clarification

There appears to be confusion in the question. Mavik and tafamidis are completely different medications:

Mavik (Trandolapril)

• Drug class: ACE inhibitor 11
• Chemical description: Ethyl ester prodrug of trandolaprilat, a nonsulfhydryl ACE inhibitor 1
• Indications:
  • Hypertension
  • Left ventricular dysfunction post-myocardial infarction 11
• Mechanism: Inhibits angiotensin-converting enzyme, reducing angiotensin II formation and lowering blood pressure

Tafamidis (Vyndaqel/Vyndamax)

• Drug class: Transthyretin (TTR) stabilizer 22345
• Indications:
  • ATTR cardiac amyloidosis (ATTR-CM) - FDA approved 225
  • ATTR polyneuropathy in some countries (not FDA-approved for neuropathy in the US) 22
• Mechanism: Binds to thyroxine-binding sites of TTR tetramer, preventing dissociation into amyloidogenic monomers 5

Clinical Context

If you are asking about Mavik specifically: It belongs to the ACE inhibitor class, used for cardiovascular conditions like hypertension and post-MI left ventricular dysfunction 11.

If you meant to ask about tafamidis: It is a first-in-class TTR stabilizer for transthyretin amyloidosis 22345.

These are entirely distinct medications with different mechanisms, indications, and clinical applications. The evidence provided shows tafamidis is not FDA-approved for neuropathy treatment, though it is approved for ATTR-CM 22.